Teacher Retirement System of Texas boosted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 284.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,138,508 shares of the company's stock after buying an additional 842,252 shares during the period. Teacher Retirement System of Texas owned 0.06% of Kenvue worth $19,639,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in Kenvue by 27.1% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 310,686 shares of the company's stock worth $5,042,000 after buying an additional 66,192 shares during the period. Renaissance Capital LLC lifted its holdings in Kenvue by 55.8% during the third quarter. Renaissance Capital LLC now owns 980,436 shares of the company's stock worth $15,912,000 after buying an additional 351,259 shares during the period. Allstate Corp purchased a new stake in Kenvue during the third quarter worth $1,152,000. Aberdeen Group plc lifted its holdings in Kenvue by 84.1% during the third quarter. Aberdeen Group plc now owns 1,411,380 shares of the company's stock worth $22,914,000 after buying an additional 644,930 shares during the period. Finally, Oak Thistle LLC purchased a new stake in Kenvue during the fourth quarter worth $1,563,000. Hedge funds and other institutional investors own 97.64% of the company's stock.
Kenvue Stock Performance
Shares of KVUE stock opened at $17.49 on Friday. The business's fifty day simple moving average is $17.82 and its 200-day simple moving average is $17.15. The company has a market cap of $33.57 billion, a PE ratio of 22.71, a PEG ratio of 3.97 and a beta of 0.61. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17.
Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.05. The business had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business's quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 earnings per share. Analysts expect that Kenvue Inc. will post 1.1 earnings per share for the current fiscal year.
Kenvue Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue's dividend payout ratio is presently 107.79%.
Analyst Ratings Changes
A number of analysts have weighed in on the company. Argus upgraded Kenvue to a "hold" rating in a report on Friday, March 6th. Barclays reduced their price target on Kenvue from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 14th. Canaccord Genuity Group upped their price target on Kenvue from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Wednesday, February 18th. Citigroup reduced their price target on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 15th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Kenvue in a research report on Wednesday, April 8th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to MarketBeat, Kenvue has a consensus rating of "Hold" and an average price target of $19.33.
Check Out Our Latest Analysis on KVUE
Kenvue Profile
(
Free Report)
Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.
The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.